156 related articles for article (PubMed ID: 12703461)
1. Monoclonal antibodies. Targeted treatment.
Mayo Clin Health Lett; 2003 Mar; 21(3):1-3. PubMed ID: 12703461
[No Abstract] [Full Text] [Related]
2. Regression of lymphoma after withdrawal of infliximab alone in an infliximab/methotrexate-treated RA patient.
Mo N; Muthu S; O'Sullivan M
Rheumatology (Oxford); 2011 Apr; 50(4):808-10. PubMed ID: 21183450
[No Abstract] [Full Text] [Related]
3. [Autoimmune aspects of treatment with TNF-alpha inhibitors].
Kolarz B; Targońska-Stepniak B; Darmochwał-Kolarz D; Majdan M
Postepy Hig Med Dosw (Online); 2007 Aug; 61():478-84. PubMed ID: 17786135
[TBL] [Abstract][Full Text] [Related]
4. [Suspected cases of severe side effects after infliximab (Remicade) in Germany].
Thürmann PA
Med Klin (Munich); 2003 Aug; 98(8):428. PubMed ID: 12928807
[No Abstract] [Full Text] [Related]
5. Tumour necrosis factor as a therapeutic target in rheumatoid arthritis and other chronic inflammatory diseases: the clinical experience with infliximab (REMICADE).
Bondeson J; Maini RN
Int J Clin Pract; 2001 Apr; 55(3):211-6. PubMed ID: 11351775
[TBL] [Abstract][Full Text] [Related]
6. Potential role of pharmacogenetics in anti-TNF treatment of rheumatoid arthritis and Crohn's disease.
Kooloos WM; de Jong DJ; Huizinga TW; Guchelaar HJ
Drug Discov Today; 2007 Feb; 12(3-4):125-31. PubMed ID: 17275732
[TBL] [Abstract][Full Text] [Related]
7. [Anti-TNF alpha agents in patients with rheumatoid arthritis refractory to conventional therapies].
González-Gay MA; Agudo M
Med Clin (Barc); 2010 May; 134(15):684-5. PubMed ID: 20176386
[No Abstract] [Full Text] [Related]
8. A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis.
van den Bemt BJ; Vos K; den Broeder AA; Blom M; Thurlings RM; Bartelds GM; Stapel SO; Barrera P; Tak PP; Nurmohamed MT; Wolbink GJ
Ann Rheum Dis; 2009 Aug; 68(8):1368-9. PubMed ID: 19605744
[No Abstract] [Full Text] [Related]
9. [Effectiveness and safety of biological therapy with adalimumab].
Fehér J; Lengyel G
Orv Hetil; 2009 Jun; 150(26):1215-22. PubMed ID: 19546078
[TBL] [Abstract][Full Text] [Related]
10. Infliximab treatment of rheumatoid arthritis and Crohn's disease.
Nahar IK; Shojania K; Marra CA; Alamgir AH; Anis AH
Ann Pharmacother; 2003 Sep; 37(9):1256-65. PubMed ID: 12921510
[TBL] [Abstract][Full Text] [Related]
11. Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level.
van Rijthoven AW; Bijlsma JW; Canninga-van Dijk M; Derksen RH; van Roon JA
Rheumatology (Oxford); 2006 Oct; 45(10):1317-9. PubMed ID: 16844698
[No Abstract] [Full Text] [Related]
12. [Tumour necrosis factor antagonists: infliximab, adalimumab and etanercept].
Breedveld FC
Ned Tijdschr Geneeskd; 2005 Oct; 149(41):2273-7. PubMed ID: 16240851
[TBL] [Abstract][Full Text] [Related]
13. Recommendations for the prevention and management of tuberculosis in patients taking infliximab.
Salmon-Ceron D; ;
Ann Med Interne (Paris); 2002 Nov; 153(7):429-31. PubMed ID: 12598827
[TBL] [Abstract][Full Text] [Related]
14. Adalimumab: human recombinant immunoglobulin g1 anti-tumor necrosis factor monoclonal antibody.
Baker DE
Rev Gastroenterol Disord; 2004; 4(4):196-210. PubMed ID: 15580154
[TBL] [Abstract][Full Text] [Related]
15. [New developments in therapy of non-Hodgkin lymphomas with monoclonal antibodies].
Buske C; Feuring-Buske M; Unterhalt M; Hiddemann W
Dtsch Med Wochenschr; 1999 Jul; 124(27):842-7. PubMed ID: 10432945
[No Abstract] [Full Text] [Related]
16. Monoclonal antibody treatment of solid tumors: a coming of age.
Murray JL
Semin Oncol; 2000 Dec; 27(6 Suppl 11):64-70; discussion 92-100. PubMed ID: 11236030
[TBL] [Abstract][Full Text] [Related]
17. Anti-adalimumab antibodies in rheumatoid arthritis patients are associated with interleukin-10 gene polymorphisms.
Bartelds GM; Wijbrandts CA; Nurmohamed MT; Wolbink GJ; de Vries N; Tak PP; Dijkmans BA; Crusius JB; van der Horst-Bruinsma IE
Arthritis Rheum; 2009 Aug; 60(8):2541-2. PubMed ID: 19644871
[No Abstract] [Full Text] [Related]
18. [Adalimumab slows the progression of rheumatoid arthritis].
Pharm Unserer Zeit; 2003; 32(1):75-6. PubMed ID: 12577764
[No Abstract] [Full Text] [Related]
19. Radiographic benefit without clinical improvement in infliximab-treated patients with rheumatoid arthritis: comment on the article by Smolen et al.
Pincus T; Yazici Y; Yazici H; Kavanaugh AF; Kremer JM; Wolfe F
Arthritis Rheum; 2005 Dec; 52(12):4044-5; author reply 4045-7. PubMed ID: 16320353
[No Abstract] [Full Text] [Related]
20. Analytical and clinical evaluation of a new immunoassay for therapeutic drug monitoring of infliximab and adalimumab.
Llinares-Tello F; de Salazar JR; Gallego JM; Soler GS; Ramírez CS; Heredia ES; García JM
Clin Chem Lab Med; 2012 Oct; 50(10):1845-7. PubMed ID: 23089717
[No Abstract] [Full Text] [Related]
[Next] [New Search]
